Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia
2 clinical trials · Condition
◉ Watch Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes (NCT06484062) | National Cancer Institute (NCI) | 2025-08-15 |
| TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts (NCT03816319) | National Cancer Institute (NCI) | 2025-03-12 |
Track Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.